EQUITY ALERT 297 0 Kommentare Rosen Law Firm Announces Investigation of Securities Claims Against Akers Biosciences, Inc. – AKER

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Akers Biosciences, Inc. (NASDAQ: AKER) resulting from allegations that Akers may have issued materially misleading business information to the investing public.

On May 21, 2018, Akers disclosed it was unable to file its Form 10-Q with the SEC for the quarter ended March 31, 2018 and that its continuing review of the “characterization of certain revenue recognition items . . . now includes certain transactions in previous quarters.” On this news, shares of Akers fell $0.058 per share or over 8% to close at $0.599 per share on May 22, 2018.

On May 29, 2018, Akers issued a press release stating that “Raymond F. Akers Jr., Ph.D has resigned as a director of the Company with immediate effect.” On this news, shares of Akers fell $0.198 or over 33% to close at $0.391 per share on May 29, 2018.

On June 1, 2018, Akers filed a letter with the SEC from Raymond Akers which stated that Dr. Akers “resigned from the Board of Directors due to significant differences regarding the policies and practices of the Board of Directors, accounting and business practices of Management, and new Counsel.”

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Akers investors. If you purchased shares of Akers please visit the firm’s website at http://www.rosenlegal.com/cases-1358.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.